Midmark India, maker of medical equipment, is planning to set up its 15th center in the near future; the manufacturing unit is said to be set up in Andhra Pradesh or in Telengana.
Suki, a California-based, health-tech startup founded by former Flipkart executive in 2017 is said to have raised a new round of capital of $15 million.
An investigation on 2 different theories about the hereditary ways in which migraines are found in family lines was conducted by a transatlantic team.
The Patient-Centered Outcomes Researcher Institute (PCORI), a study to look at more effective ways to tackle uncontrolled hypertension using mHealth, was funded $6.5 million to the researchers of the University of California and San Francisco. The research includes whether the patients can care for themselves better at home through mHealth devices, compare to the doctors’ office.
Health Canada’s new safety audit rules are going to increase costs and expected to expel some medical devices players out of the country, the new rules are expected to bring a huge shortage of products for the patients in Canada.
Expansion Includes the Joint Development of Moderna’s KRAS Oncogene Program and Other Potential mRNA Cancer Vaccines; Merck to Make Equity Investment in Moderna
The only shingles vaccine to achieve ≥90% efficacy across all age groups studied
Lately, Biotech and immunotherapy have been widely covered by media, but there’s more to healthcare than taking leaps of faith on new tech. New companies are addressing administrative functions, personalized medicine, and proactive wellness in their approach to the health industry.
Several Mobile-Health companies are joining hands to create a clinician-facing platform for assuring data quality and patient identification in remote patient monitoring programs.
iSchemaView has received FDA approval for its latest product, RAPID CTA, a 3D imaging platform for computed tomography angiography (CTA).
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.